Art

J-GLOBAL ID：202202211589996906   Reference number：22A1178798

Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in Unresectable or Metastatic Esophageal Cancer Patients With Anti-PD-1 Therapy

抗PD-1治療の切除不能または転移性食道癌患者における予後バイオマーカーとしての前処理好中球対リンパ球比【JST・京大機械翻訳】

Author (12)： Gao Yiming (1Medical School of Chinese People’s Liberation Army (PLA), Beijing, China) ,  Gao Yiming (2Department of Oncology, The First Medical Center, Chinese People’s Liberation Army (PLA) General Hospital, Beijing, China) ,  Zhang Zhibo (3Department of Cardiothoracic Surgery, The 78th Group Army Hospital of Chinese People’s Liberation Army (PLA), Mudanjiang, China) ,  Li Yao (1Medical School of Chinese People’s Liberation Army (PLA), Beijing, China) ,  Li Yao (2Department of Oncology, The First Medical Center, Chinese People’s Liberation Army (PLA) General Hospital, Beijing, China) ,  Chen Siyuan (1Medical School of Chinese People’s Liberation Army (PLA), Beijing, China) ,  Chen Siyuan (2Department of Oncology, The First Medical Center, Chinese People’s Liberation Army (PLA) General Hospital, Beijing, China) ,  Lu Jiangyue (4Harbin Medical University Cancer Hospital, Harbin, China) ,  Wu Liangliang (5Institute of Oncology, The Fifth Medical Center of Chinese People’s Liberation Army (PLA) General Hospital, Beijing, China) ,  Ma Zhiqiang (2Department of Oncology, The First Medical Center, Chinese People’s Liberation Army (PLA) General Hospital, Beijing, China) ,  Hu Yi (2Department of Oncology, The First Medical Center, Chinese People’s Liberation Army (PLA) General Hospital, Beijing, China) ,  Zhang Guoqing (2Department of Oncology, The First Medical Center, Chinese People’s Liberation Army (PLA) General Hospital, Beijing, China)
Material： Frontiers in Oncology (Web)
Volume： 12  Page： 834564  Publication year： 2022 
JST Material Number： U7089A  ISSN： 2234-943X  Document type： Article
Article type： 原著論文  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： Background: The neutrophil-to-...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=22A1178798&from=J-GLOBAL&jstjournalNo=U7089A") }}

Thesaurus term： multivariate analysis ,  inflammation ,  death ,  *lymphocyte ,  statistical method ,  survival ratio ,  inhibitor ,  *prognosis ,  *neutrophils ,  *esophageal tumor ,  *biomarker
Semi thesaurus term： 疾患進行 ,  Kaplan-Meier法 ,  *切除不能 ,  全生存率 ,  *プログラム細胞死1受容体 ,  無増悪生存率 , 【Automatic Indexing@JST】

Author keywords (5)： esophageal cancer ,  immune checkpoint inhibitor ,  programmed cell death 1 ,  neutrophil-to-lymphocyte ratio ,  prognosis

JST classification (1)： Urogenital tumors(=neoplasms)  (GM04000S)

Reference (40)：

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin (2018) 68(6):394-424. doi: doi: 10.3322/caac.21492
• Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Corvera C, Das P, et al. Esophageal and Esophagogastric Junction Cancers, Version 2.2019. NCCN Clin Pract Guidelines Oncol JNCCN (2019) 17(7):855-83. doi: doi: 10.6004/jnccn.2019.0033
• Yang YM, Hong P, Xu WW, He QY, Li B. Advances in Targeted Therapy for Esophageal Cancer. Signal Transduct Target Ther (2020) 5(1):229. doi: doi: 10.1038/s41392-020-00323-3
• Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in Combination With Chemotherapy Versus Chemotherapy Alone for Treatment of HER2-Positive Advanced Gastric or Gastro-Oesophageal Junction Cancer (ToGA): A Phase 3, Open-Label, Randomised Controlled Trial. Lancet (2010) 376(9742):687-97. doi: doi: 10.1016/s0140-6736(10)61121-x
• Amrane K, Querellou S, Schick U, Abgral R, Metges JP. Complete Metabolic Response Assessed by FDG PET/CT to Paclitaxel-Ramucirumab in Patients With Metastatic Gastroesophageal Junction Cancer. Clin Nucl Med (2020) 45(2):127-8. doi: doi: 10.1097/rlu.0000000000002882

Terms in the title (10)： PD-1 ,  治療 ,  切除不能 ,  転移性 ,  食道癌 ,  患者 ,  予後 ,  バイオマーカー ,  好中球 ,  リンパ球